Improving recovery for gynecologic cancer patients after surgery
Enhanced Recovery Protocols in Gynecological Cancer Patients: a Feasibility Study
National and Kapodistrian University of Athens · NCT06655506
This study is testing if special recovery plans can help women with gynecologic cancer recover better after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 25 Years to 85 Years |
| Sex | Female |
| Sponsor | National and Kapodistrian University of Athens (other) |
| Locations | 8 sites (Athens, Athens and 7 other locations) |
| Trial ID | NCT06655506 on ClinicalTrials.gov |
What this trial studies
This study investigates the implementation of Enhanced Recovery After Surgery (ERAS) protocols in gynecologic oncology centers in Greece. It aims to assess the feasibility and compliance of these protocols, which include pre-operative education, nutritional care, and multimodal analgesia, among others. The study will compare outcomes between patients who meet the necessary criteria for ERAS and those who do not. A quality assurance program will be established to monitor both groups throughout the perioperative period.
Who should consider this trial
Good fit: Ideal candidates are patients with gynecological cancer who have an ECOG performance status of less than 4 and an ASA score of less than 4.
Not a fit: Patients with metastatic cancer of non-gynecological origin or those unable to follow the ERAS protocol due to medical reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery times and quality of life for patients undergoing surgery for gynecologic cancer.
How similar studies have performed: Other studies have shown success with ERAS protocols in various surgical fields, indicating potential for positive outcomes in this context as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: patients with gynaecological cancer and an ECOG performance status \<4, ASA score \<4. Exclusion Criteria: patients with metastatic cancer of non-gynaecological origin patients that are not able to follow ERAS protocol due to medical reasons patients with severe debilitating comorbidities (ECOG status 4, ASA score 4-5)
Where this trial is running
Athens, Athens and 7 other locations
- First department of Obstetrics and Gynecology — Athens, Athens, Greece (RECRUITING)
- Agios Savvas Anticancer Hospital — Athens, Attica, Greece (RECRUITING)
- First department of Obstetrics and Gynecology, National and Kapodistrian University of Athens — Athens, Attica, Greece (RECRUITING)
- University of Thessaly — Larissa, Larissa, Greece (RECRUITING)
- Metaxa Anticancer Hospital — Athens, Piraeus, Greece (NOT_YET_RECRUITING)
- Aristotle University of Thessaloniki, Second department of Obstetrics and Gynecology — Thessaloniki, Thessaloniki, Greece (RECRUITING)
- Aristotle University of Thessaloniki, Third department of Obstetrics and Gynecology — Thessaloniki, Thessaloniki, Greece (RECRUITING)
- Aristotle University of Thesalloniki, Papageorgiou Hospiral — Thessaloniki, Thessaloniki, Greece (RECRUITING)
Study contacts
- Study coordinator: Nikolaos Thomakos, MD, PhD
- Email: thomakir@hotmail.com
- Phone: +302132162291
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: ERAS, Gynecologic Cancer, Perioperative Complication, Postoperative Pain, Quality of Life, Infections